| 1. | BuyHighSellLow | |
| 2. | vivmawhinney | |
| 3. | liviukq0jcynvi | |
| 4. | peterholmbeck | |
| 5. | hlatko |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | vivmawhinney 02/21/2018 Portola Pharmaceuticals Announces Results of CHMP Oral Explanations for Andexanet Alfa and Betrixaban |
| 2. | vivmawhinney 05/04/2018 Rally on! Here's Why Portola Pharmaceuticals (PTLA) Shares Jumped 20% Today |
| 3. | liviukq0jcynvi 02/21/2018 Credit Suisse reiterates Outperform rating; PT lowered to $53 from $68 |
| 4. | BuyHighSellLow 02/20/2018 positive trend vote |
| 5. | vivmawhinney 02/28/2018 Shares under pressure on reports the FDA may require additional data for Andexxa. |
| 6. | liviukq0jcynvi 03/01/2018 Portola Pharmaceuticals Inc (PTLA): Oppenheimer Lowers Price Target Amid Apprehension Circling AndexXa's Approval Timeline |
| 7. | liviukq0jcynvi 02/21/2018 Drivel. |
| 8. | peterholmbeck 03/26/2018 Portola Pharmaceuticals Receives and Plans to Appeal Negative CHMP Opinion Regarding Marketing Authorization for Betrixaban in the European Union |
| 9. | BuyHighSellLow 10/30/2017 These guys have several options |
| 10. | liviukq0jcynvi 05/04/2018 U.S. FDA Approves Portola Pharmaceuticals' Andexxa®, First and Only Antidote for the Reversal of Factor Xa Inhibitors |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Portola Pharmaceuticals, Inc.
- PTLA
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.